RxDoctor Payments Data

Rodney Kraft, MD

Sports Medicine · Fresno, CANPI 1851374979

Payments from drug & device makers

$608in general payments, 2019–2025

Across 28 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$58
  • Pfizer$57
  • Amgen$54
  • Bioventus LLC$53
  • Novo Nordisk$53
  • Anika Therapeutics, Inc.$52
  • plus $279 from 11 others

What the payments were for

  • Food & beverage$608100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$608 in reported general payments places this provider in the 35th percentile of 662 sports medicine providers in California.

See all sports medicine providers in California

Medicare billing

Part B allowed, 2024
$352,794
Medicare patients
756
Services billed
12,730

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide159$178,229
OzempicSemaglutide108$112,217
EliquisApixaban53$52,441
JardianceEmpagliflozin32$51,135
Repatha SureclickEvolocumab35$24,257
JanuviaSitagliptin Phosphate14$23,083
FarxigaDapagliflozin Propanediol15$18,854
PremarinEstrogens, Conjugated36$17,356
MyrbetriqMirabegron14$14,647
Dexlansoprazole DrDexlansoprazole14$6,791
EdarbiAzilsartan Medoxomil11$5,863
Wixela InhubFluticasone Propion/Salmeterol29$5,354
Testosterone Cypionate89$5,093
SynthroidLevothyroxine Sodium37$4,728
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen229$4,131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$45$178,229159 claims
Novo NordiskOzempic$53$112,217108 claims
PfizerEliquis, Premarin, Paxlovid$57$72,656119 claims
Boehringer IngelheimJardiance$23$51,13532 claims
AstraZenecaFarxiga$38$18,85415 claims
Arbor Pharmaceuticals, Inc.Edarbi$17$5,86311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 662 sports medicine providers in California.

Other sports medicine in Fresno

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →